News & events

Press Releases

On the 28th March 2022, OncoArendi changed its name to Molecure

Molecure has submitted a new application for approval to conduct a Phase II clinical trial for clinical candidate OATD-01 in the countries of the European Union and Norway

9 February 2024

Molecure invites to the R&D Day – an online scientific and educational meeting on February 6, 2024

29 January 2024

Molecure’s success in development of the mRNA discovery platform

12 December 2023

Molecure Announces Third Quarter 2023 Financial Results and Pipeline Highlights

31 October 2023

Molecure Announces First Half 2023 Results – Significant Financial and Operating Momentum

29 September 2023

Invitation to investor meeting 3rd October 2023, 2:00 pm (CET)

20 September 2023

Events & Presentations

R&D Day Presentation, 07.12.2022

7 December 2022

Fibrosis and Tissue Repair: From Molecules and Mechanics to Therapeutic Approaches – February 19-23, 2020 | Victoria, BC, Canada

27 February 2020

EFMC-ASMC’19 – September 1-5, 2019 | Athens, Greece

11 September 2019

ACS National Meeting & Expo – August 25 – 29, 2019 | San Diego, CA

4 September 2019

ATS- International Conference – Dallas, 17-22.05.2019

22 May 2019

EFMC – YMCS – Young Medicinal Chemist Symposium – Ljubljana 02-06.09.2018

17 September 2018